# Study of Ripertamab in Children With Frequent Relapses or Steroid-Dependent Nephrotic Syndrome

> **NCT07388810** · NA · NOT_YET_RECRUITING · sponsor: **Mao Jianhua** · enrollment: 312 (estimated)

## Conditions studied

- FRNS/SDNS
- Ripertamab

## Interventions

- **DRUG:** ripertamab
- **DRUG:** ripertamab

## Key facts

- **NCT ID:** NCT07388810
- **Lead sponsor:** Mao Jianhua
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2026-12
- **Final completion:** 2028-02
- **Target enrollment:** 312 (ESTIMATED)
- **Last updated:** 2026-02-05

## Collaborators

- Sinocelltech Ltd.

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07388810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07388810, "Study of Ripertamab in Children With Frequent Relapses or Steroid-Dependent Nephrotic Syndrome". Retrieved via AI Analytics 2026-08-08 from https://api.ai-analytics.org/clinical/NCT07388810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*